| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269628 | HPB | 2012 | 11 Pages |
Abstract
MDCT with angiography or MRI/MRCP should constitute the first imaging modality in suspected pancreatic adenocarcinomas. EUS is recommended for assessing lesions not clearly detected, but suspected, on CT/MRI and in tumours considered 'borderline resectable' on MDCT to assess vascular involvement. PET-CT in locally advanced lesions will help rule out distant metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Shailesh V. Shrikhande, Savio George Barreto, Mahesh Goel, Supreeta Arya,